Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Dense connectomic reconstruction in layer 4 of the somatosensory cortex.

Motta A, Berning M, Boergens KM, Staffler B, Beining M, Loomba S, Hennig P, Wissler H, Helmstaedter M.

Science. 2019 Nov 29;366(6469). pii: eaay3134. doi: 10.1126/science.aay3134. Epub 2019 Oct 24.

PMID:
31649140
2.

Big data in nanoscale connectomics, and the greed for training labels.

Motta A, Schurr M, Staffler B, Helmstaedter M.

Curr Opin Neurobiol. 2019 Apr;55:180-187. doi: 10.1016/j.conb.2019.03.012. Epub 2019 May 2. Review.

PMID:
31055238
3.

SynEM, automated synapse detection for connectomics.

Staffler B, Berning M, Boergens KM, Gour A, Smagt PV, Helmstaedter M.

Elife. 2017 Jul 14;6. pii: e26414. doi: 10.7554/eLife.26414.

4.

No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.

Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C; Assessment of Lescol in Renal Transplantation (ALERT) study group.

Clin Transplant. 2006 Nov-Dec;20(6):732-9.

PMID:
17100723
5.

Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.

Soveri I, Holdaas H, Jardine A, Gimpelewicz C, Staffler B, Fellström B.

Nephrol Dial Transplant. 2006 Aug;21(8):2282-9. Epub 2006 Mar 30.

PMID:
16574686
6.

Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.

Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators.

Am J Transplant. 2005 Dec;5(12):2929-36. Erratum in: Am J Transplant. 2006 Aug;6(8):1986.

7.

Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.

Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C; ALERT Study Group.

Nephrol Dial Transplant. 2005 May;20(5):974-80. Epub 2005 Mar 22.

8.

Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.

Fellström B, Holdaas H, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Staffler B, Pedersen TR; Assessment of Lescol in Renal Transplantation Study Investigators.

Transplantation. 2005 Jan 27;79(2):205-12.

PMID:
15665769
9.

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.

Mouridsen H, Gershanovich M, Sun Y, Pérez-Carrión R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Jänicke F, Pluzanska A, Dank M, Becquart D, Bapsy PP, Salminen E, Snyder R, Lassus M, Verbeek JA, Staffler B, Chaudri-Ross HA, Dugan M.

J Clin Oncol. 2001 May 15;19(10):2596-606. Erratum in: J Clin Oncol 2001 Jul 1;19(13):3302.

PMID:
11352951

Supplemental Content

Loading ...
Support Center